Exact Sciences Corporation (NASDAQ:EXAS) registered a 1.05% increase, still its new closing price is 311.35% up from the company’s 1 year high of 22.80.It posted 8.65% gains in previous 5 sessions and is now the subject of 5 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 5 buy or better ratings. The 11 stock analysts following this company have an average price target at $20.88, with individual PT in the $15.00-$26.00 range. The shares moved at $19.21, implying that brokerage firms see shares gaining about 198.29% in twelve months time.
Exact Sciences Corporation (EXAS) SEC Form 4 News
The stock is getting much attention these days as insiders are offloading shares while they posted a 43.79% rise year to date. A SVP and General Counsel at Exact Sciences Corporation (EXAS) offloaded shares in a transaction closed on Tuesday January 03, 2017. COWARD D SCOTT sold 1,535 shares in the company at $13.61 each and collected $20,001 in proceeds. COWARD D SCOTT now owns 34,918 shares in the company after this transaction. A Director in the company, THOMPSON DAVID, disclosed a transaction on Wednesday December 14, 2016 that ended up paying $138,000 from the purchase of 10,000 shares at $13.84 per share.
Exact Sciences Corporation (NASDAQ:EXAS) Upcoming Results on Tap
Exact Sciences Corporation will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $-0.37 in that period. Sales during the quarter are predicted to arrive at $33.29 million.
Earnings surprise history: Last quarter, the company posted approximately $28.11 million in revenue and EPS of $-0.36. The mean forecast was for $25.28 million and $-0.42 a share, respectively. One quarter earlier, revenue for the stock was at $21.18 million, with earnings at $-0.46/share.
Exact Sciences Corporation (EXAS) Brokerage Update
Exact Sciences Corporation (EXAS) is in Craig Hallum’s research list so their analyst rating change is noteworthy. These shares were upgraded to Buy from Hold by Craig Hallum, according to news reported on Thursday June 16, 2016.Another important research note was issued by Mizuho on Wednesday May 04, 2016.The firm downgraded EXAS to Neutral from Buy. Over the last six months and over the last three months, the shares of Exact Sciences Corporation (EXAS), have changed 5.03% and 21.51%, respectively.
